Clinical Trials Logo

Filter by:
NCT ID: NCT05934357 Active, not recruiting - Diet Habit Clinical Trials

Fiber's Utilization for Energy and Life

FUEL
Start date: May 13, 2023
Phase: N/A
Study type: Interventional

The study aims to evaluate the metabolizable energy of the typical American diet with and without the inclusion of fiber. We hypothesize that including fiber in the diet will decrease the metabolizable energy of the diet resulting in more nutrient loss into the feces and urine.

NCT ID: NCT05933525 Active, not recruiting - Diarrhea Clinical Trials

Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model

Start date: May 29, 2023
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled study to investigate if Travelan® protects healthy adult volunteers from moderate-to-severe diarrhea upon challenge with Enterotoxigenic Escherichia coli (ETEC) strain H10407.

NCT ID: NCT05933304 Active, not recruiting - COVID-19 Clinical Trials

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Start date: December 18, 2020
Phase:
Study type: Observational

This is an observational cohort study to evaluate real-world vaccine effectiveness and durability of Moderna COVID-19 vaccine among a diverse population at Kaiser Permanente Southern California (KPSC). The primary objective of this study is to evaluate the vaccine effectiveness (VE) of receipt of Moderna COVID-19 vaccine in preventing SARS-CoV-2 infection and severe COVID-19 disease. SARS-CoV-2 infection will be defined as a positive antigen test result as well as a positive molecular diagnostic test among symptomatic or asymptomatic participants or a COVID-19 diagnosis code. Severe COVID-19 disease will be defined as COVID-19 hospitalization or mortality.

NCT ID: NCT05931471 Active, not recruiting - Gut Microbiome Clinical Trials

Yogurt and GI Health

Start date: September 19, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to assess mucosal immune function responses in the gastrointestinal (GI) tract to twice-daily yogurt consumption. Previous research has shown that dairy yogurt intake can benefit gastrointestinal health. The current study will determine whether a dietary intervention with dairy yogurt will improve mucosal immunity and the gut microbiome.

NCT ID: NCT05931432 Active, not recruiting - Depression, Anxiety Clinical Trials

A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID

Thrive
Start date: October 12, 2023
Phase: N/A
Study type: Interventional

For this project the broad research objective is to evaluate the effectiveness of an enhanced digital wellbeing program in improving well-being, depression, anxiety, stress, resilience, and job satisfaction of physicians. The intent of the investigators is that this will enable a proactive culture of well-being and mental health support for the broader healthcare workforce during the multiple phases of the pandemic. The investigator's approach evaluates existing digital models which can be executed in a timely fashion and rapidly scaled for use across other health systems. Aim 1: Conduct interviews of URM and women physicians to identify barriers and facilitators to accessing and receiving digital well-being, mental health, and culturally sensitive support resources. Aim 2: Through a randomized controlled trial (RCT) investigate the immediate and long-term effect of a comprehensive well-being focused intervention (push text messaging, resource support, semi-facilitated peer groups hosted by Cobalt) vs. usual care on well-being, depression, anxiety, stress, resilience, and job satisfaction of physicians practicing in the era of COVID.

NCT ID: NCT05926830 Active, not recruiting - Clinical trials for Chronic Venous Insufficiency

Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study

VEINRESET
Start date: October 12, 2023
Phase: N/A
Study type: Interventional

This is a multi-center series assessment with a planned accrual of 70 patients with diagnosed symptomatic primary GSV insufficiency. Patients will be consented at a Pre-Study Visit and evaluated for eligibility and for baseline characteristics of the disease. Patients will receive treatment with Sonovein for the targeted segments of GSV. At follow-up visits at 7 days (1 to 10 days), 3 months (+/- 20 days), 6 months (+/- 25 days), and 12 months (+/- 30 days) changes in veins and flow characteristics will be evaluated by ultrasound, and patient well-being, including pain which will be evaluated by patient-reported VAS evaluations. Continued follow-up for a total of 12 months will be completed prior to subject study exit. Adverse events (AE) will be assessed at every study visit following HIFU treatment.

NCT ID: NCT05926141 Active, not recruiting - Adolescent Behavior Clinical Trials

Advanced Cooking Education Pilot Study

Start date: September 28, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to assess the impact of an in-person multi-component Advanced Cooking Education (ACE) 4-H after school program. The ACE Program consists of mindfulness, nutrition education, cooking labs, and professional development activities.

NCT ID: NCT05925426 Active, not recruiting - Spinal Deformity Clinical Trials

Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery

Start date: July 1, 2022
Phase:
Study type: Observational

The actual quality of Red Blood Cells (RBCs) salvaged during spinal deformity surgery has never been rigorously evaluated. To characterize the usefulness of intraoperatively salvaged RBCs in spinal deformity surgery. The study team hopes to answer the following questions: 1) What is the quality of RBCs salvaged during spine surgery? 2) Does intraoperatively transfused RBC salvage impact clinical outcomes?

NCT ID: NCT05925127 Active, not recruiting - COVID-19 Clinical Trials

Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines

COVID-19
Start date: October 16, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant (r) spike (S) protein nanoparticle (SARS-CoV-2 rS) vaccines with Matrix-M™ adjuvant (NVX-CoV2373 [prototype Wuhan vaccine with Matrix-M adjuvant] or NVX-CoV2601 [Omicron XBB.1.5 subvariant vaccine with Matrix-M adjuvant]).

NCT ID: NCT05925114 Active, not recruiting - Obesity Clinical Trials

Safety and Efficacy Study of S-309309 in Obese Adults

Start date: June 21, 2023
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.